Analyst Coverage

Analyst Coverage

Analyst Firm Contact
Waqar Syed
AltaCorp Capital
+1-720-683-6705
Bill Selesky
Argus Research Corp.
+1-646-747-5462
Barry MacCarthy
Atlantic Equities
+44-207-382-2935
Chase Mulvehill
Bank of America/Merrill Lynch
+1-713-247-6033
David Anderson
Barclays
+1-212-526-4016
Dan Boyd
BMO Capital Markets
+1-713-547-0812
Paul Kuklinski
Boston Energy Research
+1-442-256-4407
Luke M. Lemoine
Capital One Securities, Inc
+1-504-593-6174
Scott Gruber
Citi
+1-212-816-6000
Nokta Haithum
Clarksons Platou Securities
+1-212-317-8161
Marc Bianchi
Cowen and Company
+1-646-562-1393
Jacob Lundberg
Credit Suisse
+1-212-325-6785
Feyman Jeon
Daishin Securities
+1-822-769-3082
James West
Evercore ISI
+1-212-446-5638
Angeline Sedita
Goldman Sachs
+1-212-902-1000
Kevin Simpson
Griffin Securities, Inc.
+1-646-442-4168
Abhishek Kumar
HSBC
+91-22-6630-3057
Brad Handler
Jefferies & Co.
+1-212-336-7429
Daniel Burke
Johnson Rice & Company
+1-504-584-1213
Sean Meakim
JP Morgan
+1-212-622-6684
Walt Chancellor
Macquarie Research
+1-612-237-3081
Connor Lynagh
Morgan Stanley
+1-212-296-8145
Preston Caldwell
Morningstar, Inc.
+1-312-696-6605
Bill Herbert
Piper Jaffray
+1-713-223-7898
Praveen Narra
Raymond James
+1-713-278-5288
Kurt Hallead
RBC Capital Markets
+1-512-708-6356
Michael Urban
Seaport Global Securities, LLC
+1-713-549-4000
Tommy Moll
Stephens Inc.
+1-501-377-6306
Stephen Gengaro
Stifel Nicolaus and Company
+1-973-549-4000
Chuck Minervino
Susquehanna Financial Group
+1-610-617-2685
Byron Pope
Tudor Pickering & Co.
+1-713-333-7690
Sasha Sanwal
UBS Equities
+1-212-713-4907
Christopher Voie
Wells Fargo Securities, LLC
+1-713-319-1245
Blake Gendron
Wolfe Research
+1-646-582-9272
Longdley Zephirin
Zephirin Group, Inc.
+1-917-563-2512

Halliburton is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Halliburton's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Halliburton or its management. Halliburton does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.